Czechia· CZ-0158152
ALBUREX
A albumin product containing human albumin solution, registered in Czechia by CSL Behring GmbH, Marburg. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Albumin is registered in 13 of 19 countries.
Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Albumin · ATC B05AA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- HUMAN ALBUMIN SOLUTION
- Manufacturer
- CSL Behring GmbH, Marburg
- Country
- Czechia (CZ)
- ATC code
- B05AA01
- ATC class
- Albumin
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl01581521X100MLCZK 2671.22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Albumin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAlbiominBiotest Pharma GmbH
- PolandAlbiomin 20%Biotest Pharma GmbH
- IcelandAlbumanProthya Biosolutions Netherlands B.V.
- BelgiumAlburex 20 200 mg/mlCSL Behring
- United StatesALBUTEINGRIFOLS USA, LLC
- United KingdomAlba 20% solution for infusion 100ml bottlesScottish National Blood Transfusion Service
- Japan人血清アルブミン日本血液製剤機構
- GermanyAlbiominBiotest Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Albiomin, Albunorm
- Belgium · Albunorm, Human Albumin Baxalta
- Bulgaria · Aлбунорм, Албиомин
- Cyprus · Albiomin, Albuman
- Germany · Albiomin, Albunorm
- Denmark · Albumin Baxalta, Albumin Grifols
- Estonia · Albumin Baxalta, Albunorm
- Spain · Albiomin, Albuplan
- Finland · Albuman, Albumin Baxalta
- France · Albumine Humaine, Albunorm
- United Kingdom (Northern Ireland) · Albunorm, Albutein
- Greece · Albiomin, Albumine Lfb
- Croatia · Albutein, Flexbumin
- Hungary · Albumon, Albunorm
- Ireland · Albunorm, Albutein
- Iceland · Albuman, Albumin Baxalta
- Italy · Albiomin, Albital
- Lithuania · Albumin Baxalta, Albunorm
- Luxembourg · Albunorm, Human Albumin Baxalta
- Latvia · Albumin Baxalta, Albunorm
- Malta · Albiomin, Albunorm
- Netherlands · Albuman, Albunorm
- Norway · Albumin Baxalta, Albumin Grifols
- Poland · Albiomin, Albunorm
- Portugal · Albiomin, Albumina Humana Baxalta
- Romania · Albiomin, Albumină Umană Baxalta
- Sweden · Albumin Baxalta, Albumin Octapharma
- Slovenia · Albunorm, Flexbumin
- Slovakia · Albunorm, Albutein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ded1a2c0-5742-4eef-8e51-0869fcdc00ab GET /v1/drugs/ded1a2c0-5742-4eef-8e51-0869fcdc00ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INF SOL",
"source": "sukl",
"strength": "200G/L",
"pack_size": "1X100ML",
"substance": "HUMAN ALBUMIN SOLUTION",
"cz_kod_sukl": "0158152",
"product_type": "KR/A",
"substance_codes": "5554",
"registration_state": "R",
"registration_number": "59/245/10-C"
}See everything about albumin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.